| mRNA |
BMS-754807 |
FIMM |
pan-cancer |
AAC |
0.017 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.9 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |